Form 4: Elanco Animal Health EVP/CFO Acquires Stock Units

Robert M. VanHimbergen, EVP and CFO of Elanco Animal Health Inc., acquired deferred stock units representing the right to receive company common stock.

Summary

• Robert M. VanHimbergen, Executive Vice President and Chief Financial Officer of Elanco Animal Health Inc., acquired 8.6337 deferred stock units on April 3, 2026.
• These units represent the right to receive one share of Elanco's common stock or its cash equivalent.
• The acquisition was made under a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), indicating a pre-planned transaction.
• The deferred stock units are set to settle in cash or shares upon termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine executive stock unit acquisition under a pre-existing plan rather than a significant new development or change in company performance.

Positives

• The transaction was executed under a Rule 10b5-1(c) plan, suggesting a structured and pre-determined approach to executive compensation and stock ownership.
• Acquisition of stock units by a key executive like the CFO can be interpreted as a sign of confidence in the company's future performance.

Negatives

• The filing does not provide details on the cost or value of the acquired deferred stock units at the time of acquisition, only the number of units.

Risks

• The value of the deferred stock units is subject to fluctuations in Elanco's stock price until settlement.
• The settlement of these units is contingent upon specific events such as termination of employment or a specified future year, introducing timing uncertainty.

Future Outlook

The future outlook for the acquired deferred stock units depends on the company's stock performance and the terms of the Executive Deferral and Stock Match Plan regarding settlement.

Industry Context

StockSavvy.ai notes that the acquisition of deferred stock units by an executive is a common practice in the animal health industry as part of executive compensation and incentive structures, aligning management's interests with shareholders.

Stakeholder Impact

• Shareholders: The acquisition itself does not directly impact share price but reflects executive compensation practices. The underlying value of the units is tied to share performance.
• Employees: The Executive Deferral and Stock Match Plan, under which these units were acquired, may be part of broader employee incentive programs.
• Management: The CFO's acquisition of stock units aligns his financial interests with those of other shareholders.

Next Steps

• Settlement of deferred stock units upon termination of employment or during a specified future year.
• Potential receipt of Elanco common stock or cash equivalent based on settlement terms.

Key Dates

Keywords

Elanco Animal Health, ELAN, Form 4, Insider Trading, Stock Options, Deferred Stock Units, Executive Compensation, CFO, SEC Filing